1070
Present results suggested that coadministration of mexiletine increased blood tizanidine concentrations and enhanced tizanidine pharmacodynamics in terms of reduction in blood pressure and adverse symptoms.
 tizanidine pharmacodynamics in terms of reduction in blood pressure and adverse symptoms: Effect; coadministration of mexiletine increased blood tizanidine concentrations: Treatment; mexiletine: Treatment.Drug; tizanidine: Treatment.Drug; mexiletine: Combination.Drug; tizanidine: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 tizanidine pharmacodynamics in terms of reduction in blood pressure and adverse symptoms: Effect; coadministration of mexiletine increased blood tizanidine concentrations: Treatment; mexiletine: Treatment.Drug; tizanidine: Treatment.Drug; mexiletine: Combination.Drug; tizanidine: Combination.Drug